Research by Isabelle Gagnon-Arpin

(Displaying 1 to 20 of 25) | Page: 1 2 | Next »
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 14 pages | August 2022 | by Isabelle Gagnon-Arpin, Isabella Moroz, Nicholas Moroz, Chad Leaver
L’approvisionnement fondé sur la valeur (AFV) est une approche avancée en matière d’achat qui répond au défi épineux d'améliorer les soins et les résultats pour les...
Le Conference Board du Canada | 15 pages | August 2022 | by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
This data briefing, an update to The Conference Board of Canada’s 2017 Understanding the Gap, analyzes the availability of prescription drug coverage across the country and the...
The Conference Board of Canada | 22 pages | July 2022 | by Isabelle Gagnon-Arpin, Wanlin Chen, Chad Leaver
Cette publication en ligne porte sur l’assurance-médicaments d'ordonnance au Canada et sur l’écart entre les personnes couvertes et les personnes non couvertes.
The Conference Board of Canada | Website | May 2022 | by Isabelle Gagnon-Arpin
This online experience looks at prescription drug insurance in Canada and the gap between the insured and the uninsured.
The Conference Board of Canada | Website | May 2022 | by Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Saudi Arabia. Large-scale public health interventions...
The Conference Board of Canada | 20 pages | January 2021 | by Isabelle Gagnon-Arpin, Junyi Feng
In this issue briefing, the authors model the economic burden of cardiovascular disease in Mexico—the direct costs of delivering health care services and the indirect costs from...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors model the economic burden of cardiovascular disease in Colombia—the direct costs of delivering health care services and the indirect costs from...
The Conference Board of Canada | 20 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors model the economic burden of cardiovascular disease in the United Arab Emirates—the direct costs of delivering health care services and the...
The Conference Board of Canada | 18 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Saudi Arabia. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Mexico. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Colombia. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in the United Arab Emirates. Large-scale public...
The Conference Board of Canada | 18 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
This report examines cancer mortality rates in Canada, with a focus on lung, colorectal, and prostate cancers, and compares our national and provincial rates against those of 16...
The Conference Board of Canada | 30 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Monika Slovinec D’Angelo
Les immunomodulateurs ralentissent les lésions au cerveau et diminuent la fréquence des poussées chez les patients atteints de la sclérose en plaques. Alors, pourquoi les Canadiens...
Le Conference Board du Canada | 53 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo
Disease-modifying therapies (DMTs) slow down brain lesions and ease relapses in multiple sclerosis patients—but why can’t Canadians easily access them? This primer examines DMTs’...
The Conference Board of Canada | 48 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo
Which interventions may yield the biggest health and economic impacts on cardiovascular disease (CVD) in Brazil? This issue briefing assesses the impact of two different, yet complementary,...
The Conference Board of Canada | 20 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors examine the direct and indirect costs of cardiovascular disease and their impact on the public health care system and economy of Brazil, from...
The Conference Board of Canada | 22 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin
Will Canada be able to keep up with Canada’s growing eye needs? This impact paper quantifies the value of ophthalmology from a population health, health care system, and broader...
The Conference Board of Canada | 37 pages | November 2020 | by Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo, Zhenzhen Ye
This impact paper identifies the contribution that various health care cost drivers, including COVID-19, have on projections for health care expenditures in Canada.
The Conference Board of Canada | 49 pages | October 2020 | by Isabelle Gagnon-Arpin, Greg Hermus
(Displaying 1 to 20 of 25) | Page: 1 2 | Next »